Corient Capital Partners’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$265K Buy
3,486
+5
+0.1% +$369 0.02% 502
2022
Q2
$265K Buy
3,481
+518
+17% +$39.3K 0.02% 516
2022
Q1
$235K Buy
2,963
+108
+4% +$7.86K 0.02% 633
2021
Q4
$209K Buy
+2,855
New +$192K 0.01% 648

Other funds holding INCY

Corient Capital Partners's INCY Position: Q3 2022 in Review

Corient Capital Partners increased its Incyte (INCY) stake by 0.14% in Q3 2022, buying an estimated $369 and bringing the position to 3,486 shares worth $265K. The position accounts for 0.02% of the portfolio, ranked #502.

Corient Capital Partners first reported a position in INCY in Q4 2021 and has held it in 4 quarters since. 536 funds tracked by Wall St. Rank hold INCY as of Q3 2022.

  • Corient Capital Partners held 3,486 shares of Incyte worth $265K as of Q3 2022.
  • Corient Capital Partners bought 5 Incyte shares in Q3 2022, an estimated $369.
  • Incyte made up 0.02% of Corient Capital Partners's portfolio in Q3 2022, its #502 holding.
  • Corient Capital Partners first reported a position in Incyte in Q4 2021 and has held it in 4 quarters since.
  • 536 funds tracked by Wall St. Rank held Incyte as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.